Panel Discussion: Exploring Vectors Beyond AAV and the Unique Durability Challenges and Opportunities They Present

Time: 4:00 pm
day: Day Two AM


• Assessing immunogenicity concerns relating to non-viral vectors

• Understanding their potential to enable redosing and minimize durability concerns using lentivirus vectors

• Explore clinical updates of non-viral vectors and lentivirus vectors to improve durability